New England Journal of Medicine · 2011 · 364 citations · 14 references
In these two 12-week trials, linaclotide significantly reduced bowel and abdominal symptoms in patients with chronic constipation. Additional studies are needed to evaluate the potential long-term risks and benefits of linaclotide in chronic constipation. (Funded by Ironwood Pharmaceuticals and Forest Research Institute; ClinicalTrials.gov numbers, NCT00765882 and NCT00730015.).
14
Michael Field, Liselotte Graf, W Laird et al. · Proceedings of the National Academy of Sciences · 1978 · 564 citations · Full text
Microbial Pathogens, Escherichia Coli, Microbial Physiology +16